This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Barge RM, Brouwer RE, Beersma MF, Starrenburg CW, Zwinderman AH, Hale G et al. Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome. Bone Marrow Transplant 2000; 27: 1053–1058.
Broers AE, van der Holt B, Haze S, Braakman E, Gratama JW, Lowenberg B et al. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation. Exp Hematol 2005; 33: 912–919.
Zecca M, Nobili B, Ramenghi U, Perrotta S, Amendola G, Rosito P et al. Rituximab for treatment of refractory autoimmune haemolytic anemia in children. Blood 2003; 101: 3857–3861.
Chen FE, Owen I, Savage D, Roberts I, Apperley J, Goldman JM et al. Late onset of haemolysis and red cell autoimmunisation after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 491–495.
Drobyski WR, Potluri J, Sauer D, Gottschall JL . Autoimmune hemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 17: 1093–1099.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hilgendorf, I., Wolff, D., Wilhelm, S. et al. T-cell-depleted stem cell boost for the treatment of autoimmune haemolytic anaemia after T-cell-depleted allogeneic bone marrow transplantation complicated by adenovirus infection. Bone Marrow Transplant 37, 977–978 (2006). https://doi.org/10.1038/sj.bmt.1705356
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705356